Altered purine and pyrimidine metabolism in erythrocytes with purine nucleoside phosphorylase deficiency
Irving H. Fox(Takeda (United States)), William N. Arnold(Community Health Systems - Lutheran Hospital), Jan Kaminska(University of Michigan), Erwin W. Gelfand(National Jewish Health), Kenneth Rich(University of Illinois Chicago), N. Lawrence Edwards(University of Michigan)
Cited by 5
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
|Gastroenterology|2014|714
Treatment of Ulcerative Colitis with a Humanized Antibody to the α <sub>4</sub> β <sub>7</sub> Integrin
|New England Journal of Medicine|2005|694